116 related articles for article (PubMed ID: 20038204)
1. Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteins.
Bandi P; Pagliaccetti NE; Robek MD
J Interferon Cytokine Res; 2010 Mar; 30(3):123-34. PubMed ID: 20038204
[TBL] [Abstract][Full Text] [Related]
2. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN.
Alcamí A; Symons JA; Smith GL
J Virol; 2000 Dec; 74(23):11230-9. PubMed ID: 11070021
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of interferons by ectromelia virus.
Smith VP; Alcami A
J Virol; 2002 Feb; 76(3):1124-34. PubMed ID: 11773388
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia virus blocks Stat1-dependent and Stat1-independent gene expression induced by type I and type II interferons.
Mann BA; Huang JH; Li P; Chang HC; Slee RB; O'Sullivan A; Anita M; Yeh N; Klemsz MJ; Brutkiewicz RR; Blum JS; Kaplan MH
J Interferon Cytokine Res; 2008 Jun; 28(6):367-80. PubMed ID: 18593332
[TBL] [Abstract][Full Text] [Related]
5. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.
Brandt TA; Jacobs BL
J Virol; 2001 Jan; 75(2):850-6. PubMed ID: 11134298
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6.
Lu Y; Stuart JH; Talbot-Cooper C; Agrawal-Singh S; Huntly B; Smid AI; Snowden JS; Dupont L; Smith GL
Proc Natl Acad Sci U S A; 2019 Jun; 116(24):11997-12006. PubMed ID: 31127039
[TBL] [Abstract][Full Text] [Related]
7. Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts.
Trilling M; Le VT; Zimmermann A; Ludwig H; Pfeffer K; Sutter G; Smith GL; Hengel H
J Virol; 2009 Apr; 83(8):3684-95. PubMed ID: 19211768
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
Waibler Z; Anzaghe M; Frenz T; Schwantes A; Pöhlmann C; Ludwig H; Palomo-Otero M; Alcamí A; Sutter G; Kalinke U
J Virol; 2009 Feb; 83(4):1563-71. PubMed ID: 19073732
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.
Liu R; Moss B
J Virol; 2018 May; 92(9):. PubMed ID: 29444943
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
Deng L; Dai P; Ding W; Granstein RD; Shuman S
J Virol; 2006 Oct; 80(20):9977-87. PubMed ID: 17005676
[TBL] [Abstract][Full Text] [Related]
11. M135R is a novel cell surface virulence factor of myxoma virus.
Barrett JW; Sypula J; Wang F; Alston LR; Shao Z; Gao X; Irvine TS; McFadden G
J Virol; 2007 Jan; 81(1):106-14. PubMed ID: 17065210
[TBL] [Abstract][Full Text] [Related]
12. IFN-λ1 Displays Various Levels of Antiviral Activity In Vitro in a Select Panel of RNA Viruses.
Plotnikova M; Lozhkov A; Romanovskaya-Romanko E; Baranovskaya I; Sergeeva M; Kаа K; Klotchenko S; Vasin A
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452467
[TBL] [Abstract][Full Text] [Related]
13. Interferon lambda in respiratory viral infection: immunomodulatory functions and antiviral effects in epithelium.
Liu YG; Jin SW; Zhang SS; Xia TJ; Liao YH; Pan RL; Yan MZ; Chang Q
Front Immunol; 2024; 15():1338096. PubMed ID: 38495892
[TBL] [Abstract][Full Text] [Related]
14. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing.
Li WX; Li H; Lu R; Li F; Dus M; Atkinson P; Brydon EW; Johnson KL; García-Sastre A; Ball LA; Palese P; Ding SW
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1350-5. PubMed ID: 14745017
[TBL] [Abstract][Full Text] [Related]
15. HDAC5 enhances IRF3 activation and is targeted for degradation by protein C6 from orthopoxviruses including Monkeypox virus and Variola virus.
Lu Y; Zhao Y; Gao C; Suresh S; Men J; Sawyers A; Smith GL
Cell Rep; 2024 Mar; 43(3):113788. PubMed ID: 38461415
[TBL] [Abstract][Full Text] [Related]
16. Vaccinia Virus Arrests and Shifts the Cell Cycle.
Martin CK; Samolej J; Olson AT; Bertoli C; Wiebe MS; de Bruin RAM; Mercer J
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216024
[TBL] [Abstract][Full Text] [Related]
17. A role for Z-DNA binding in vaccinia virus pathogenesis.
Kim YG; Muralinath M; Brandt T; Pearcy M; Hauns K; Lowenhaupt K; Jacobs BL; Rich A
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):6974-9. PubMed ID: 12777633
[TBL] [Abstract][Full Text] [Related]
18. IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo.
Sommereyns C; Paul S; Staeheli P; Michiels T
PLoS Pathog; 2008 Mar; 4(3):e1000017. PubMed ID: 18369468
[TBL] [Abstract][Full Text] [Related]
19. Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses.
Mohamed MR; Rahman MM; Lanchbury JS; Shattuck D; Neff C; Dufford M; van Buuren N; Fagan K; Barry M; Smith S; Damon I; McFadden G
Proc Natl Acad Sci U S A; 2009 Jun; 106(22):9045-50. PubMed ID: 19451633
[TBL] [Abstract][Full Text] [Related]
20. Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs.
Hagmaier K; Stock N; Precious B; Childs K; Wang LF; Goodbourn S; Randall RE
J Gen Virol; 2007 Mar; 88(Pt 3):956-966. PubMed ID: 17325370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
